EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib

Epidermal growth factor receptor (EGFR) mutations are strong determinants of tumour response to EGFR tyrosine kinase inhibitors in non-small-cell lung cancer (NSCLC). Pleural effusion is a common complication of lung cancer. In this study, we assessed the feasibility of detection of EGFR mutations i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, H, Fujiwara, Y, Sone, T, Kunitoh, H, Tamura, T, Kasahara, K, Nishio, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360588/
https://www.ncbi.nlm.nih.gov/pubmed/17060940
http://dx.doi.org/10.1038/sj.bjc.6603428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360588/
https://www.ncbi.nlm.nih.gov/pubmed/17060940
http://dx.doi.org/10.1038/sj.bjc.6603428

Ejemplares similares